Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
Clinical trial NCT05626101 · UNKNOWN
Trial details
- NCT number
- NCT05626101
- Sponsor
- Al-Azhar University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-09-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.